Several possible studies
Story checked
Five-session SBRT preserves quality of life before pancreatic cancer surgery (opens in a new tab)
news-medical.net · 2026-09-28
Short answer
Several possible studiesNo clear answer.
More than one paper fits the article's details, and none fits well enough to single out. Checking claims against the wrong study would be worse than not checking them at all.
Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.
Share this check
The story
Five-session SBRT preserves quality of life before pancreatic cancer surgery
news-medical.net · 2026-09-28
The story’s checkable claims.
Read the original story (opens in a new tab)NewsLink checks it
Several studies could be the source of this story.
More than one paper fits the article's details, and none fits well enough to single out. Checking claims against the wrong study would be worse than not checking them at all.
Open claim evidenceSearch result
Several studies could fit.
More than one paper fits the article's details, and none fits well enough to single out. Checking claims against the wrong study would be worse than not checking them at all.
Source layer
The paper behind the story
The source record for this check.
The research anchor for the report.
- Points somewhere elsepresented as the new finding
https://www.astro.org/news-and-publications/news-and-media-center/news-releases/2026/short-course-radiation-therapy-better-preserves-physical-function-before-pancreatic-cancer-surgery
Evidence layer
Claim by claim
What the story asserts. With no source study, there is nothing to check these against.
Reading mode
Scan verdicts. Open evidence only when needed.
Claim 1 of 6Not checkedPatients preparing for pancreatic cancer surgery maintained better physical function and experienced less fatigue with five treatments of stereotactic body radiation therapy (SBRT) than with 28 treatments of conventional radiation therapy given with chemotherapy, according to a randomized phase 2 clinical trial.View evidenceHide evidence
As statedfive treatments vs 28 treatments
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 2 of 6Not checkedRates of cancer remaining in the lymph nodes after preoperative treatment, the trial's primary endpoint, did not differ significantly between the groups.View evidenceHide evidence
As stated41% vs 38% among those who underwent surgery
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 3 of 6Not checkedResearchers also found no significant differences in pathologic tumor response, complication rates or surgical margins.View evidenceHide evidence
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 4 of 6Not checkedLocal or regional recurrence was uncommon during a median follow-up of approximately 3.4 years, and none of the differences in recurrence, progression-free survival or overall survival were statistically significant, although the trial was not powered to detect survival differences.View evidenceHide evidence
As statedmedian progression-free survival approximately 14 vs 22 months; median overall survival 26 vs 43 months; 3-year survival 43% vs 58%
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 5 of 6Not checkedThe clearest difference between the treatment approaches emerged in patient-reported outcomes during the preoperative treatment period, with SBRT associated with better physical function, overall physical health and less fatigue, and the differences were no longer significant after surgery.View evidenceHide evidence
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 6 of 6Not checkedThe findings should be interpreted in the context of a single-institution phase 2 trial, and larger multicenter studies are needed to determine whether the results can be reproduced in other settings.View evidenceHide evidence
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Method layer
No single source study was found.
NewsLink still surfaces nearby research so you can inspect the field instead of a single paper.
Nearby research
No exact source, but these papers are close.
PubMed, Europe PMC, Crossref · 15 candidate papers
Current practices and challenges in the management of nonmetastatic pancreatic adenocarcinoma: results of an EORTC survey.
ESMO Gastrointestinal Oncology · 2026 · PubMed, Europe PMC
Re: Patient-reported Outcomes After Prostate Stereotactic Body Radiotherapy at 5 yr: Results from the PACE-B Trial
European Urology · 2026 · Crossref
A Randomized Controlled Trial of Stereotactic Body Radiation Therapy Versus Chemoradiation Following Induction Chemotherapy in Borderline Resectable and Locally Advanced Pancreatic Cancer.
2025 · Europe PMC
Conventionally Fractionated Radiotherapy (CFRT) Versus Stereotactic Body Radiotherapy (SBRT) for Locally Advanced Pancreatic Cancer: A Systematic Review and Meta-Analysis of Comparative Studies.
Cancers · 2026 · PubMed
Stereotactic body radiotherapy in pancreatic ductal adenocarcinoma: interpreting the results of the SPAN-C trial
Annals of Pancreatic Cancer · 2026 · Crossref
And 10 more candidates considered.